CAM
CNCE

Cormorant Asset Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Cormorant Asset Management’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-538,422
Closed -$5.54M – 79
2016
Q4 		$5.54M Buy
+538,422
New +$5.54M 0.75% 38